AstraZeneca receives marketing permission for Osimertinib to treat non-small cell lung cancer in…
Osimertinib (TagrissoTM) will be used as 1st line treatment for NSCLC offering potential new standard of care
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
ACG Inspection partners with Verinetics to further strengthen fight against falsified medicines
With this partnership, ACG Inspections is looking to implement an add-on security layer to provide Multi-Factor authentication to…
Novo Nordisk Pharmatech in agreement with Signet Chemical Corporation
The agreement will lead to the distribution of pharmaceutical range of quaternary ammonium compounds to the healthcare industry in…
Fix DAVA portal, says industry to DGFT
Faced with delays at ports and possible product recalls, industry hopes the DGFT will fix the issues with the DAVA portal as well…
Opportunity for biotech firms to pursue drug candidates targeting metabolic disorders
The GlobalData report found that big pharma companies lag behind small bio-techs in R&D efforts
Consulate General of Canada, PHARMEXCIL, Trade & Invest British Columbia host roadshow in…
The day-long session in Mumbai consisted of presentations from top Canadian pharmaceutical companies
China orders recall of defective vaccines
The recall indicated the scandal gripping China may have spread to foreign markets, dealing a potentially heavy blow to the…
Glenmark bags FDA acceptance for Ryaltris
The drug is used for patients suffering from seasonal allergic rhinitis
Kilitch Drugs eyes African markets
To set up manufacturing unit on 12400 sq mt of land in Ethiopia